The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
NCT01023802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2013-05-10
Summary
In patients with breast cancer who undergo neoadjuvant chemotherapy or neoadjuvant hormone therapy molecular breast imaging (MBI) is an accurate test for assessing response rate to neoadjuvant therapy.
Conditions
- Neoadjuvant Therapy
- Chemotherapy
- Hormone Replacement Therapy
- Breast Cancer
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Dietlind L. Wahner-Roedler, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- United States
Study Locations
More Related Trials
-
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
NCT00620373 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
NCT01653964 ·Status: COMPLETED ·Phase: NA
-
Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions
NCT01806558 ·Status: COMPLETED ·Phase: NA
-
Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer
NCT03289195 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT05042687 ·Status: RECRUITING ·Phase: NA
-
Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy
NCT02679586 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy
NCT05301790 ·Status: UNKNOWN
-
Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)
NCT00890994 ·Status: COMPLETED
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
Histology of Functional Density in Postmenopausal Breast
NCT01240278 ·Status: COMPLETED
-
Use of Low-dose Molecular Breast Imaging for the Detection of Small Breast Lesions
NCT01285440 ·Status: COMPLETED
-
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
NCT03568448 ·Status: ACTIVE_NOT_RECRUITING
-
Tc99m Sestamibi Molecular Breast Imaging
NCT02324387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
NCT01687790 ·Status: COMPLETED ·Phase: NA
-
Molecular Breast Imaging in Screening Breast Cancer
NCT03082456 ·Status: COMPLETED ·Phase: NA
-
Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up
NCT01723124 ·Status: TERMINATED ·Phase: NA
-
DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
NCT01564368 ·Status: COMPLETED ·Phase: NA
-
Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery
NCT00776308 ·Status: COMPLETED
-
Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy
NCT00580086 ·Status: COMPLETED
-
Molecular Breast Imaging in Patients With a History of Bloody Nipple Discharge
NCT00566280 ·Status: COMPLETED ·Phase: NA
-
Screening in Myocardial Perfusion Patients
NCT00943241 ·Status: COMPLETED
-
Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue
NCT03220893 ·Status: COMPLETED ·Phase: NA
-
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767 ·Status: COMPLETED
-
MRI and Early Decision-making in Chemotherapy for Breast Cancer
NCT02449824 ·Status: COMPLETED
-
Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients
NCT02024074 ·Status: TERMINATED ·Phase: PHASE1